sulfamoxol
sulfamoxol structure
|
Common Name | sulfamoxol | ||
|---|---|---|---|---|
| CAS Number | 729-99-7 | Molecular Weight | 267.30400 | |
| Density | 1.411g/cm3 | Boiling Point | 481ºC at 760 mmHg | |
| Molecular Formula | C11H13N3O3S | Melting Point | 197-199℃ | |
| MSDS | Chinese USA | Flash Point | 244.7ºC | |
| Symbol |
GHS07 |
Signal Word | Warning | |
|
Adverse reactions to sulphonamide and sulphonamide-trimethoprim antimicrobials: clinical syndromes and pathogenesis.
Adverse Drug React. Toxicol. Rev. 15(1) , 9-50, (1996)
|
|
|
Combination of trimethoprim with sulfonamides other than sulfamethoxazole.
Rev. Infect. Dis. 4(2) , 411-8, (1982) Early in the development of trimethoprim (TMP), the response to the drug was less than enthusiastic. Preliminary clinical trials were performed with sulfonamides that were unsuitable partners. On the basis of bacteriologic and pharmacokinetic evidence, sulfam... |
|
|
Use of p-benzoquinone for the spectrophotometric determination of certain sulphonamides.
J. Pharm. Biomed. Anal. 9(7) , 531-8, (1991) A simple spectrophotometric method for the determination of 15 sulphonamides in bulk and in dosage forms is described. The method is based on the interaction of p-benzoquinone with sulphonamides in 0.1 M hydrochloric acid. The resulting chromophore is measure... |
|
|
Comparative pharmacokinetics of co-trifamole and co-trimoxazole to 'steady state' in normal subjects.
Br. J. Clin. Pharmacol. 14(3) , 437-43, (1982)
|
|
|
[Supristol suspension in pediatrics].
Lille Med. 25(10) , 611-2, (1980)
|
|
|
Ondansetron attenuates co-morbid depression and anxiety associated with obesity by inhibiting the biochemical alterations and improving serotonergic neurotransmission.
J. Endocrinol. 91(2) , 299-303, (1981) In our earlier study we reported the antidepressant activity of ondansetron in obese mice. The present study investigates the effect of ondansetron on depression and anxiety associated with obesity in experimental mice with biochemical evidences. Male Swiss a... |
|
|
In vitro studies with combinations of sulfamoxole and trimethoprim (co-trifamole).
Curr. Med. Res. Opin. 8(2) , 128-33, (1982) Chequerboard studies with sulfamoxole and trimethoprim against urinary pathogens showed that the combination was never antagonistic but usually showed little or no synergistic effect. An exception was with the inherently sulphonamide-resistant Strep. faecalis... |
|
|
Synergism between trimethoprim and sulfonamide in urine: does it exist?
Clin. Ther. 4(2) , 103-8, (1981) In a randomized, crossover, multiple dose study, ten healthy volunteers received the recommended dosages of cotrimoxazole (80 mg trimethoprim and 400 mg sulfamethoxazole) and co-tri-famole (80 mg trimethoprim and 400 mg sulfamoxole) for five days each. Urinar... |
|
|
Coulometric determination of sulphisomidine, sulphamethoxydiazine and sulphamoxole.
J. Pharm. Biomed. Anal. 9(2) , 199-201, (1991)
|
|
|
Chancroid in El Salvador. Increasing incidence, clinical features, and therapeutics.
Int. J. Dermatol. 27(4) , 243-5, (1988) Ninety-five cases of chancroid were studied during a 6-month period in a dermatologic service in San Salvador; 88 (92.6%) were men and 7 (7.4%) were women, with a ratio of 12.5:1. The minimum age was 13 years and the maximum 46, with an average of 21 years. I... |